J&J signs deal with Fate for off-the-shelf immunotherapies
Fate Therapeutics and J&J will collaborate to progress candidates against four tumor-associated antigens.
Archives for April 6, 2020
FDA looks to accelerate plasma therapies for coronavirus
US FDA looks to coordinate and speed up the development of blood-derived therapies to treat patients with COVID-19.
Daiichi pays $225m to access gene therapy production platform
Daiichi partners with Ultragenyx to utilize its HeLa producer cell line platform for commercial-scale gene therapy production.